These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism. van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730 [TBL] [Abstract][Full Text] [Related]
53. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462 [No Abstract] [Full Text] [Related]
54. [Bullous skin rash in a 61-year-old man]. Phelippeau M; Bonnet D; Laurenty AP; Meyer N; Apoil PA; Selves J; Alric L; Saadoun D Rev Med Interne; 2011 Feb; 32(2):120-3. PubMed ID: 21239087 [No Abstract] [Full Text] [Related]
55. [Characteristic of adverse reactions after blood components transfusion]. Król D; Mazur B; Drybańska B Przegl Lek; 2009; 66(8):453-8. PubMed ID: 20043593 [TBL] [Abstract][Full Text] [Related]
56. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD]. Takahashi K Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283 [TBL] [Abstract][Full Text] [Related]
57. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803 [TBL] [Abstract][Full Text] [Related]
58. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future. Klapper EB; Goldfinger D Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560 [TBL] [Abstract][Full Text] [Related]
59. Perspectives on transfusion-associated graft-versus-host disease. Jeter E Int J Artif Organs; 1994 Jan; 17(1):1-4. PubMed ID: 8188393 [No Abstract] [Full Text] [Related]
60. Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT). van Els C; Bakker A; Zwaan F; van Rood JJ; Goulmy E Transplant Proc; 1989 Feb; 21(1 Pt 3):2987-8. PubMed ID: 2468249 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]